Atazanavir Sulfate CAS 229975-97-7 Nadiifnimada ≥99.0% API Warshada Kahortagga HIV-ga HIV-1
U keeni Nadiif Sarreysa iyo Tayo Deggan
Magaca Kiimikada: Atazanavir Sulfate
CAS: 229975-97-7
HIV-1 Protease Inhibitor
API Tayada Sare, Wax soo saarka Ganacsiga
Magaca Kiimikada | Atazanavir Sulfate |
La mid ah | BMS-232632 Sulfate |
Lambarka CAS | 229975-97-7 |
Lambarka CAT | RF-API71 |
Heerka Saamiyada | Kaydka, Miisaanka Wax-soo-saarka Ilaa boqollaal Kiilogaram |
Qaanuunka molecular | C38H52N6O7.H2SO4 |
Miisaanka Molecular | 802.93 |
Meesha dhalaalaysa | 195.0-198.0 ℃ |
Solubility | Aan ku milmin Biyaha, Ku milmay DMSO |
Kaydinta Muddada Dheer | Ku kaydi wakhtiga dheer at -20 ℃ |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Budada cad ama Off-Cad |
Sulfate | 12.0 ~ 12.5% |
Khasaare xagga qalajinta | ≤0.50% |
Hadhaaga dabka | ≤0.10% |
Biraha culus | ≤20pm |
Xumaanta Keliya | ≤0.30% |
Wadarta wasakhda | ≤1.0% |
Daaqadda/Qalabaynta | ≥99.0% (HPLC) |
pH | 5.0-8.0 |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | HIV-1 Protease Inhibitor Anti-HIV |
Xidhmada: Dhalo, Bac aluminium biil ah, Durbaan kartoonada, 25kg/Drum, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.
Atazanavir Sulfate (BMS-232632 Sulfate) (CAS: 229975-97-7) waa nooc milix ah oo sulfate ah oo atazanavir ah kaas oo ah difaac aadka u doorta HIV-1 protease inhibitor, waa protease inhibitor ee ugu horreeya ee loo oggolaaday maamul maalinle ah.Atazanavir Sulfate waa substrate iyo horjooge CYP3A4, iyo inhibitor iyo kicin P-glycoprotein (P-gp).Atazanavir Sulfate sidoo kale waa SARS-CoV 3CLpro inhibitor leh IC50 oo ah 3.49 μM.Atazanavir Sulfate waa azapeptide iyo HIV-protease inhibitor oo loo isticmaalo daawaynta caabuqa HIV iyo AIDS marka lagu daro wakiilada kale ee ka hortagga HIV, waxaa soo saaray oo bilaabay Bristol-Myers Squibb (BMS), iyada oo hoos timaada shatiga aduunka Novartis, daawaynta caabuqa HIV.Atazanavir waxa laga bilaabay Maraykanka sidii Reyataz™ bishii Luulyo 2003. Ka hortagga fayraska.Atazanavir wuxuu muujiyay inuu guud ahaan ka awood badan yahay shanta hadda la ansixiyay ee HIV-1 protease inhibitors.Atazanavir waxay si xushmad leh u joojisaa habka fayraska-gaar ah ee fayraska Gag iyo Gag-Pol polyproteins ee unugyada HIV-1 ee qaba HIV-1 iyadoo lagu xirayo goobta firfircoon ee HIV-1 protease, sidaas darteed ka hortagga sameynta virions baaluq.Atazanavir ma aha mid ka hortag ah HIV-2.